Average-risk women overestimate ovarian cancer risk

Average-risk women overestimate ovarian cancer risk

(HealthDay)—Average-risk, postmenopausal women overestimate their risk of ovarian cancer, but report low cancer worry, according to a study published in the March issue of the American Journal of Obstetrics and Gynecology.

Laura L. Holman, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues surveyed 925 average-risk, enrolled in the normal-risk ovarian screening study. The authors sought to assess the women's baseline knowledge of risk and perceptions toward ovarian cancer screening (OCS). Baseline surveys included risk perception, the Cancer Worry Scale, State-Trait Anxiety Inventory (STAI), and the Short Form-36 Health Survey, as well as surveys relating to and OCS acceptability.

The researchers found that participants estimated the mean lifetime ovarian cancer risk as 29.9 percent, considerably higher than the actual risk of 1.4 percent in the United States. More than one-third (35.4 percent) of participants estimated their lifetime risk to be ≥50 percent, and only 2.8 percent estimated their risk correctly. Cancer worry was low, with a median score of 7 out of 24, and anxiety was similar to published norms for this age group (STAI-State and STAI-Trait scores of 30 and 29, respectively, out of 80). Almost all respondents (97.2 percent) agreed or strongly agreed that the benefits of OCS outweighed the difficulties. Reluctance to undergo OCS was rarely due to time constraints, pain, or embarrassment (1.1, 2.0, and 1.9 percent, respectively).

"The discrepancy between knowledge of and attitudes toward ovarian cancer risk highlights the need for educational efforts in this area," the authors write.

One author disclosed financial ties to the pharmaceutical industry. A second author is a faculty member at Massachusetts General Hospital, which has licensed the Risk of Ovarian Cancer Algorithm.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Excess weight a risk factor for ovarian cancer

Mar 11, 2014

(HealthDay)—A new report reveals that excess weight raises the risk of yet another kind of cancer, with the latest results linking levels of body fat to ovarian tumors.

Biomarkers predict time to ovarian cancer recurrence

Aug 15, 2013

Ovarian cancer often remains undetected until it is at an advanced stage. Despite positive responses to initial treatment, many patients are at risk of tumor recurrence. A multitude of genetic markers have been implicated ...

Recommended for you

Ob-gyn guidance issued for young cancer patient concerns

Jul 25, 2014

(HealthDay)—Young cancer patients and survivors may have gynecologic concerns, which should be managed before, during, and after treatment, according to a Committee Opinion published in the August issue ...

Common blood thinner for pregnant women proven ineffective

Jul 24, 2014

It's a daily injection to the belly for pregnant women at risk of developing blood clots and it's ineffective, according to a clinical trial led by researchers at The Ottawa Hospital and published today by the prestigious ...

Improving life before it begins

Jul 22, 2014

A group of Mexican specialists in fetal medicine have successfully performed over 200 surgeries on unborn babies, inside the womb of the mother. Doctors, grouped under the signature Fetal Medicine Mexico, ...

User comments